Search - tctmd.com

Displaying 261 - 280 of 1754

Sort: Relevancy | Date

Presentation TCT 2024

TCT 149: Institutional Volume and Failure to Rescue in Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry

Presenter: Jayakumar Sreenivasan

October 27, 2024

News Conference News EACTS 2024

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Yael L. Maxwell

October 21, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Todd Neale

September 30, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Presentation ESC 2024

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

Presenter: Volker Rudolph

August 31, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years in Medicare Population

News Daily News

Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years Post-TAVI

Yael L. Maxwell

July 26, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

News Daily News

Holistic Approach to Cardiac Surgery Can Sharply Cut Opioid Use

Caitlin E. Cox

July 18, 2024

Advertisement

TCT 149: Institutional Volume and Failure to Rescue in Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

What’s Going to Be Big at TCT 2024?

AI-Based CT Can Accurately Screen Patients for TMVR

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

TCTMD’s Top 10 Most Popular Stories for August 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years Post-TAVI

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

FDA Medical Devices Chief Jeff Shuren Announces Retirement

Holistic Approach to Cardiac Surgery Can Sharply Cut Opioid Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content